Reaching for the cloud: on the lessons learned from grid computing technology transfer process to the biomedical community.

Reaching for the cloud: on the lessons learned from grid computing technology transfer process to the biomedical community.

Pure scientists corresponding to physicists pioneered the sharing of computing sources, which led to the creation of the Grid. The inter area switch technique of this know-how has hitherto been an intuitive course of with out in depth evaluation. Some difficulties going through the life science neighborhood on this switch might be understood utilizing the Bozeman’s “Effectiveness Mannequin of Know-how Switch”. Bozeman’s and classical know-how switch approaches take care of applied sciences which have achieved sure stability.
Grid and Cloud options are applied sciences, that are nonetheless in flux. We present how Grid computing creates new difficulties within the switch course of that aren’t thought of in Bozeman’s mannequin. We present why the success of healthgrids needs to be measured by the certified scientific human capital and the alternatives created, and never primarily by the market affect.
We conclude with suggestions that may assist enhance the adoption of Grid and Cloud options into the biomedical neighborhood. These outcomes give a extra concise clarification of the difficulties many life science IT tasks are going through within the late funding durations, and present leveraging steps that may assist overcoming the “vale of tears”.

Biomedical alerts monitoring based mostly in cellular computing.

The primary goal of this mission consists within the improvement of a biomedical instrumentation prototype for acquisition, processing and transmission of biomedical alerts. These biomedical alerts are acquired after which processed with a microcontroller. After processing, all knowledge are despatched to a communication interface that may ship this data to a private laptop or a cellular phone.
The prototype developed, which is a digital blood stress meter, is meant to permit distant monitoring of sufferers dwelling in areas with restricted entry to medical help or scarce medical sources. We consider that this improvement could possibly be useful to enhance folks’s high quality of life, in addition to to permit an enchancment within the authorities attendance indices.

Cloud computing: a brand new enterprise paradigm for biomedical data sharing.

We study how the biomedical informatics (BMI) neighborhood, particularly consortia that share knowledge and functions, can benefit from a brand new useful resource referred to as “cloud computing”. Clouds typically provide sources on demand. In most clouds, expenses are pay per use, based mostly on giant farms of cheap, devoted servers, typically supporting parallel computing. Substantial economies of scale doubtlessly yield prices a lot decrease than devoted laboratory techniques and even institutional knowledge facilities.
General, even with conservative assumptions, for functions that aren’t I/O intensive and don’t demand a totally mature atmosphere, the numbers prompt that clouds can typically present main enhancements, and needs to be significantly thought of for BMI. Methodologically, it was very advantageous to formulate analyses when it comes to element applied sciences; specializing in these specifics enabled us to bypass the cacophony of other definitions (e.g., precisely what does a cloud embrace) and to investigate alternate options that make use of among the element applied sciences (e.g., an establishment’s knowledge middle).
Reaching for the cloud: on the lessons learned from grid computing technology transfer process to the biomedical community.
Relative analyses had been one other nice simplifier. Quite than itemizing absolutely the strengths and weaknesses of cloud-based techniques (e.g., for safety or knowledge preservation), we deal with the modifications from a selected place to begin, e.g., particular person lab techniques. We regularly discover a tough parity (in precept), however one wants to look at particular person acquisitions–is a loosely managed lab transferring to a nicely managed cloud, or a tightly managed hospital knowledge middle transferring to a poorly safeguarded cloud?

Multidimensional AM-FM fashions and strategies for biomedical picture computing.

This paper supplies an summary of multidimensional AM-FM strategies for analyzing medical pictures and movies. During the last decade, a number of new AM-FM demodulation strategies have been developed. We offer a dialogue of what many of those strategies share in widespread, and provides some particulars on current, Hilbert-based approaches.
Medical picture functions vary from medical picture segmentation, decision enhancement, classification, reconstruction to new strategies for video movement estimation. A short abstract of options for future work on this space can also be given.

Ahead-calculated analytical interferograms in pass-through photon-based biomedical transillumination.

Lately, we’ve got launched a transillumination approach for biomedical analysis. The approach, pass-through photon-based transillumination, depends on interferometric measurements to recuperate the knowledge of curiosity. On this work, we current the forward-calculated analytical interferograms that describe the habits of the system. Stochastic modeling of radiation interacting with tissue permits dedication of amplitude and part parameters, indispensable for computation of the interferograms.

Anti-RPSA Alexa Fluor® 488

A4-829-C100 0.1 mg
EUR 310

Anti-CD40 antibody (Alexa-fluor 488)

STJ170000 100 µg
EUR 393
Description: CD40 (48 to 50 kDa) is a transmembrane glycoprotein mainly expressed on the surface of B cells and also expressed on monocytes, dendritic cells, and thymic epithelium. CD40 is a member of the tumor necrosis factor (TNF) receptor superfamily, which includes the low affinity nerve growth factor (NGF) receptor and CD95/Fas. CD40 is the receptor for CD40 ligand. CD40L (CD40L, CD154, gp39, and TRAM) belongs to the TNF gene family and is expressed more widely than CD40, predominantly on activated CD4+ T cells. Following interaction with CD40 ligand, CD40 mediates a number of major immunoregulatory functions, central to the control of thymus dependent humoral immunity and may be critical in the development of cell mediated immune responses. Other biological actions include B cell homotypic adhesion, proliferation, immunoglobulin isotype switch, and secretion. Activation of CD40 has also been shown to inhibit the growth of certain B cell lymphomas and to induce the death of transformed cells of mesenchymal or epithelial origin

Anti-LAMP3 antibody (Alexa-fluor 488)

STJ170004 100 µg
EUR 393
Description: The dendritic cell lysosomal-associated membrane protein (DC-LAMP)/CD208 is a type I integral transmembrane glycoprotein mostly homologous to CD68, of about 45 kDa in mouse and 90 kDa in human (glycosylation), with a bipartite C-terminal structure divided by a serine/proline rich region, a transmembrane domain and a conserved tyrosine-based lysosomal targeting motif in its cytoplasmic tail. Initially cloned as a specific marker of human mature dendritic cells (DCs), DC-LAMP has been subsequently shown to be expressed in alveolar type II pneumocytes. In both cell types, the molecule is found in the limiting membrane of intracellular multi-lamellar bodies, known as MIIC (MHC class II compartments) in human mature DCs and as lung surfactant-containing lamellar bodies in type II pneumocytes. In the latter cell type, DC-LAMP expression is also detected at the cell surface.

Anti-LAMP3 antibody (Alexa-fluor 546)

STJ170005 100 µg
EUR 393
Description: The dendritic cell lysosomal-associated membrane protein (DC-LAMP)/CD208 is a type I integral transmembrane glycoprotein mostly homologous to CD68, of about 45 kDa in mouse and 90 kDa in human (glycosylation), with a bipartite C-terminal structure divided by a serine/proline rich region, a transmembrane domain and a conserved tyrosine-based lysosomal targeting motif in its cytoplasmic tail. Initially cloned as a specific marker of human mature dendritic cells (DCs), DC-LAMP has been subsequently shown to be expressed in alveolar type II pneumocytes. In both cell types, the molecule is found in the limiting membrane of intracellular multi-lamellar bodies, known as MIIC (MHC class II compartments) in human mature DCs and as lung surfactant-containing lamellar bodies in type II pneumocytes. In the latter cell type, DC-LAMP expression is also detected at the cell surface.

Anti-LAMP3 antibody (Alexa-fluor 647)

STJ170006 100 µg
EUR 393
Description: The dendritic cell lysosomal-associated membrane protein (DC-LAMP)/CD208 is a type I integral transmembrane glycoprotein mostly homologous to CD68, of about 45 kDa in mouse and 90 kDa in human (glycosylation), with a bipartite C-terminal structure divided by a serine/proline rich region, a transmembrane domain and a conserved tyrosine-based lysosomal targeting motif in its cytoplasmic tail. Initially cloned as a specific marker of human mature dendritic cells (DCs), DC-LAMP has been subsequently shown to be expressed in alveolar type II pneumocytes. In both cell types, the molecule is found in the limiting membrane of intracellular multi-lamellar bodies, known as MIIC (MHC class II compartments) in human mature DCs and as lung surfactant-containing lamellar bodies in type II pneumocytes. In the latter cell type, DC-LAMP expression is also detected at the cell surface.

Anti-IL3RA antibody (Alexa-fluor 488)

STJ170009 100 µg
EUR 393
Description: IL3 exerts its biologic activity through its interaction with a cell surface receptor that consists of two subunits. The a subunit (CD123) specifically binds IL3, whereas the ß subunit is required for signaling and is common to the GMCSFR and IL5-R. 107D2.08 and 106C2.02 mAbs were obtained after mouse immunization with sorted human tonsillar PDC. Both clones strongly stain PDCs and basophils, weakly stain monocytes, CD34+ derived DCs and CD11c+ DC, while no staining is observed on T, B, NK cells as well as on mono-derived DCs. Staining with 107D2.08 and 106C2.02 mAbs are maintained on sorted PDC cultured in the presence of IL3 and CD40L, but lost when IL3 alone is added to the culture. The recognition of the IL3Ra chain by 107D2.08 and 106C2.02 was confirmed by transfection studies. 107D2.08 appeared to be the most appropriate clone for in situ studies. 107D2.08 allowed the first observation of IL3Ra+ cells in breast tumor microenvironment

Anti-IL3RA antibody (Alexa-fluor 546)

STJ170010 100 µg
EUR 393
Description: IL3 exerts its biologic activity through its interaction with a cell surface receptor that consists of two subunits. The a subunit (CD123) specifically binds IL3, whereas the ß subunit is required for signaling and is common to the GMCSFR and IL5-R. 107D2.08 and 106C2.02 mAbs were obtained after mouse immunization with sorted human tonsillar PDC. Both clones strongly stain PDCs and basophils, weakly stain monocytes, CD34+ derived DCs and CD11c+ DC, while no staining is observed on T, B, NK cells as well as on mono-derived DCs. Staining with 107D2.08 and 106C2.02 mAbs are maintained on sorted PDC cultured in the presence of IL3 and CD40L, but lost when IL3 alone is added to the culture. The recognition of the IL3Ra chain by 107D2.08 and 106C2.02 was confirmed by transfection studies. 107D2.08 appeared to be the most appropriate clone for in situ studies. 107D2.08 allowed the first observation of IL3Ra+ cells in breast tumor microenvironment

Anti-IL3RA antibody (Alexa-fluor 647)

STJ170011 100 µg
EUR 393
Description: IL3 exerts its biologic activity through its interaction with a cell surface receptor that consists of two subunits. The a subunit (CD123) specifically binds IL3, whereas the ß subunit is required for signaling and is common to the GMCSFR and IL5-R. 107D2.08 and 106C2.02 mAbs were obtained after mouse immunization with sorted human tonsillar PDC. Both clones strongly stain PDCs and basophils, weakly stain monocytes, CD34+ derived DCs and CD11c+ DC, while no staining is observed on T, B, NK cells as well as on mono-derived DCs. Staining with 107D2.08 and 106C2.02 mAbs are maintained on sorted PDC cultured in the presence of IL3 and CD40L, but lost when IL3 alone is added to the culture. The recognition of the IL3Ra chain by 107D2.08 and 106C2.02 was confirmed by transfection studies. 107D2.08 appeared to be the most appropriate clone for in situ studies. 107D2.08 allowed the first observation of IL3Ra+ cells in breast tumor microenvironment

Anti-CD207 antibody (Alexa-fluor 488)

STJ170014 100 µg
EUR 393
Description: Langerin/CD207 is a transmembrane C-type lectin receptor (CLR) of epidermal and mucosal Langerhans cells (LCs) that induces Birbeck's granule formation. Langerin features a single carbohydrate recognition domain (CRD) with mannose-type specificity in its extracellular portion. Langerin is unique among the CLRs in that it contains an intracellular domain with a proline-rich motif. Langerin expression has not been reported outside the DC system. (Valladeau J et al, 1999, Eur.J.Immunol., 29:2695-2704; Valladeau J et al, 2000 Immunity, 12 : 71-81; Kashihara M et al, 1986, J.Invest.Derm., 87 :602-607 Ito T et al, 1999, J.Immunol., 163 :1409-1419 ;Saeland S & Valladeau J, CD207 (Langerin) Workshop reports 2002, Leukocyte-Typing VII, White Cell Diff Antigens, D. Mason et al, Eds, Oxford University Press:306-307)

Anti-CD207 antibody (Alexa-fluor 546)

STJ170015 100 µg
EUR 393
Description: Langerin/CD207 is a transmembrane C-type lectin receptor (CLR) of epidermal and mucosal Langerhans cells (LCs) that induces Birbeck's granule formation. Langerin features a single carbohydrate recognition domain (CRD) with mannose-type specificity in its extracellular portion. Langerin is unique among the CLRs in that it contains an intracellular domain with a proline-rich motif. Langerin expression has not been reported outside the DC system. (Valladeau J et al, 1999, Eur.J.Immunol., 29:2695-2704; Valladeau J et al, 2000 Immunity, 12 : 71-81; Kashihara M et al, 1986, J.Invest.Derm., 87 :602-607 Ito T et al, 1999, J.Immunol., 163 :1409-1419 ;Saeland S & Valladeau J, CD207 (Langerin) Workshop reports 2002, Leukocyte-Typing VII, White Cell Diff Antigens, D. Mason et al, Eds, Oxford University Press:306-307)

Anti-CD207 antibody (Alexa-fluor 647)

STJ170016 100 µg
EUR 393
Description: Langerin/CD207 is a transmembrane C-type lectin receptor (CLR) of epidermal and mucosal Langerhans cells (LCs) that induces Birbeck's granule formation. Langerin features a single carbohydrate recognition domain (CRD) with mannose-type specificity in its extracellular portion. Langerin is unique among the CLRs in that it contains an intracellular domain with a proline-rich motif. Langerin expression has not been reported outside the DC system. (Valladeau J et al, 1999, Eur.J.Immunol., 29:2695-2704; Valladeau J et al, 2000 Immunity, 12 : 71-81; Kashihara M et al, 1986, J.Invest.Derm., 87 :602-607 Ito T et al, 1999, J.Immunol., 163 :1409-1419 ;Saeland S & Valladeau J, CD207 (Langerin) Workshop reports 2002, Leukocyte-Typing VII, White Cell Diff Antigens, D. Mason et al, Eds, Oxford University Press:306-307)

Anti-IL7R antibody (Alexa-fluor 488)

STJ170020 100 µg
EUR 393
Description: The IL7-R consists of 2 chains, IL-7R known as CD127 and common cytokine receptor chain known as CD132. A 75 to 80kDa human IL-7 receptor has been cloned that belongs to hematopoietic cytokinereceptor super family. R34-34, raised against human leukemic pre-B cells, recognized a molecule expressed on normal B cell precursors but not on mature B cells. This antibody specifically reverted IL-7 mediated growth inhibition of leukemic BCP (normal B cells precursors) and mature T cells. IL-7R expression is dramatically influenced by cytokines and antigens. This IL-7R displays both high and low affinity for its ligand (IL-7). Inhibitory and proliferative effects of IL-7 can be mediated through the same receptor on various lineages. CD4+ memory T cells express high level of IL-7R Subsets that express it generally require it, including progenitors of T and B cells, naïve and memory T cells. (Pandrau-Garcia D et al, 1994, Blood, 83, 3613-9 Mazzucchelli R et al, Nat. Review Immunol., 2007,7, 144-54)

Anti-IL7R antibody (Alexa-fluor 546)

STJ170021 100 µg
EUR 393
Description: The IL7-R consists of 2 chains, IL-7R known as CD127 and common cytokine receptor chain known as CD132. A 75 to 80kDa human IL-7 receptor has been cloned that belongs to hematopoietic cytokinereceptor super family. R34-34, raised against human leukemic pre-B cells, recognized a molecule expressed on normal B cell precursors but not on mature B cells. This antibody specifically reverted IL-7 mediated growth inhibition of leukemic BCP (normal B cells precursors) and mature T cells. IL-7R expression is dramatically influenced by cytokines and antigens. This IL-7R displays both high and low affinity for its ligand (IL-7). Inhibitory and proliferative effects of IL-7 can be mediated through the same receptor on various lineages. CD4+ memory T cells express high level of IL-7R Subsets that express it generally require it, including progenitors of T and B cells, naïve and memory T cells. (Pandrau-Garcia D et al, 1994, Blood, 83, 3613-9 Mazzucchelli R et al, Nat. Review Immunol., 2007,7, 144-54)

Anti-IL7R antibody (Alexa-fluor 647)

STJ170022 100 µg
EUR 393
Description: The IL7-R consists of 2 chains, IL-7R known as CD127 and common cytokine receptor chain known as CD132. A 75 to 80kDa human IL-7 receptor has been cloned that belongs to hematopoietic cytokinereceptor super family. R34-34, raised against human leukemic pre-B cells, recognized a molecule expressed on normal B cell precursors but not on mature B cells. This antibody specifically reverted IL-7 mediated growth inhibition of leukemic BCP (normal B cells precursors) and mature T cells. IL-7R expression is dramatically influenced by cytokines and antigens. This IL-7R displays both high and low affinity for its ligand (IL-7). Inhibitory and proliferative effects of IL-7 can be mediated through the same receptor on various lineages. CD4+ memory T cells express high level of IL-7R Subsets that express it generally require it, including progenitors of T and B cells, naïve and memory T cells. (Pandrau-Garcia D et al, 1994, Blood, 83, 3613-9 Mazzucchelli R et al, Nat. Review Immunol., 2007,7, 144-54)

Goat anti Mouse IgG1 (Alexa Fluor 488)

43R-1649 500 ug
EUR 570
Description: Goat anti Mouse IgG1 secondary antibody (Alexa Fluor 488)

Anti-Hu CD16 Alexa Fluor® 488

A4-646-T100 100 tests
EUR 269

Alpha Fluor™ 532 acid [equivalent to Alexa Fluor™ 532 acid]

1795 10 mg
EUR 393
  • R-phrase: R20, R21, R22
  • H-Phrase: H303, H313, H333
  • Symbol for dangerous compounds: Xn
  • UNSPEC Code: 12171501

Mouse IgG1-Alexa 555 conjugate (isotype control)

20102-101-A555 50 Tests
EUR 263

AF350 Phalloidin [equivalent to Alexa Fluor® 350 phalloidin]

23150 300 Tests
EUR 306
  • R-phrase: R23, R24, R25
  • H-Phrase: H301, H311, H331
  • Symbol for dangerous compounds: T
  • UNSPEC Code: 12352200

AF488 Phalloidin [equivalent to Alexa Fluor® 488 phalloidin]

23153 300 Tests
EUR 306
  • R-phrase: R23, R24, R25
  • H-Phrase: H301, H311, H331
  • Symbol for dangerous compounds: T
  • UNSPEC Code: 12352200

AF594 Phalloidin [equivalent to Alexa Fluor® 594 phalloidin]

23158 300 Tests
EUR 306
  • R-phrase: R23, R24, R25
  • H-Phrase: H301, H311, H331
  • Symbol for dangerous compounds: T
  • UNSPEC Code: 12352200

AF350-streptavidin conjugate [Streptavidin, Alexa Fluor™ 350 Conjugate]

16890 1 mg
EUR 176
  • R-phrase: R20, R21, R22
  • H-Phrase: H303, H313, H333
  • Symbol for dangerous compounds: Xn
  • UNSPEC Code: 12171501

AF488-streptavidin conjugate [Streptavidin, Alexa Fluor™ 488 Conjugate]

16891 1 mg
EUR 176
  • R-phrase: R20, R21, R22
  • H-Phrase: H303, H313, H333
  • Symbol for dangerous compounds: Xn
  • UNSPEC Code: 12171501

AF594-streptavidin conjugate [Streptavidin, Alexa Fluor™ 594 Conjugate]

16892 1 mg
EUR 176
  • R-phrase: R20, R21, R22
  • H-Phrase: H303, H313, H333
  • Symbol for dangerous compounds: Xn
  • UNSPEC Code: 12171501

Donkey anti Goat IgG (H + L) (Alexa Fluor 594)

43R-ID005AF 500 ug
EUR 338
Description: Donkey anti Goat IgG (H + L) secondary antibody (Alexa Fluor 594)

Donkey anti Rat IgG (H + L) (Alexa Fluor 594)

43R-ID022AF 500 ug
EUR 364
Description: Donkey anti Rat IgG (H + L) secondary antibody (Alexa Fluor 594)

Donkey anti Goat IgG (H + L) (Alexa Fluor 647)

43R-ID028AF 500 ug
EUR 430
Description: Donkey anti Goat IgG (H + L) secondary antibody (Alexa Fluor 647)

Donkey anti Rat IgG (H + L) (Alexa Fluor 594)

43R-ID047AF 500 ug
EUR 462
Description: Donkey anti Rat IgG (H + L) secondary antibody (Alexa Fluor 594)

Donkey anti Chicken IgY (H + L) (Alexa Fluor 594)

43R-ID056AF 500 ug
EUR 343
Description: Donkey anti Chicken IgY secondary antibody (H + L) (Alexa Fluor 594)

Donkey anti Chicken IgY (H + L) (Alexa Fluor 647)

43R-ID060AF 300 ug
EUR 425
Description: Donkey anti Chicken IgY (H + L) (Fab'2) (Alexa Fluor 647)

Rabbit anti Chicken IgY (H + L) (Alexa Fluor 594)

43R-IR016AF 1 mg
EUR 281
Description: Rabbit anti Chicken IgY (H + L) secondary antibody (Alexa Fluor 594)

Anti-Hu CD72 Alexa Fluor® 488

A4-310-T100 100 tests
EUR 269

Anti-Bov CD9 Alexa Fluor® 488

A4-354-C100 0.1 mg
EUR 269

Anti-Hu CD30 Alexa Fluor® 700

A7-455-T100 100 tests
EUR 269

Anti-Hu CD94 Alexa Fluor® 700

A7-727-T100 100 tests
EUR 269

Anti-Hu CD56 Alexa Fluor® 700

A7-789-T100 100 tests
EUR 269

Goat Anti-Mouse IgG(H+L) Alexa Fluor 594–conjugated

S0005 200ul
EUR 376

Goat Anti-Rabbit IgG(H+L) Alexa Fluor 594–conjugated

S0006 200ul
EUR 376

Goat Anti-Rabbit IgG(H+L) Alexa Fluor 647–conjugated

S0013 200ul
EUR 304

Goat Anti-Mouse IgG(H+L) Alexa Fluor 647–conjugated

S0014 200ul
EUR 304

Goat Anti-Mouse IgG(H+L) Alexa Fluor 488–conjugated

S0017 200ul
EUR 304

Goat Anti-Rabbit IgG(H+L) Alexa Fluor 488–conjugated

S0018 200ul
EUR 304

Donkey anti Goat IgG (H + L) (Fab 2) (Alexa Fluor 594)

43R-ID012AF 300 ug
EUR 410
Description: Donkey anti Goat IgG (H + L) secondary antibody (Fab'2) (Alexa Fluor 594)

Donkey Anti-Goat IgG (H+L), Alexa Fluor® 594 Conjugated

Ab8011-001 1mg
EUR 334

Donkey Anti-Rabbit IgG (H+L), Alexa Fluor® 488 Conjugated

Ab8032-001 0.5mg
EUR 435

Anti-Hu CD3 zeta (pY153) Alexa Fluor® 488

A4-686-C100 0.1 mg
EUR 269

Anti-Hu CD3 zeta (pY72) Alexa Fluor® 488

A4-712-C100 0.1 mg
EUR 269

Anti-Hu CD3 zeta (pY142) Alexa Fluor® 488

A4-730-C100 0.1 mg
EUR 269

Anti-Hu CD3 zeta (pY111) Alexa Fluor® 488

A4-737-C100 0.1 mg
EUR 269

Anti-Hu CD3 zeta (pY153) Alexa Fluor® 647

A6-686-C100 0.1 mg
EUR 269

Anti-Hu CD3 zeta (pY72) Alexa Fluor® 647

A6-712-C100 0.1 mg
EUR 269

Anti-Hu CD3 zeta (pY142) Alexa Fluor® 647

A6-730-C100 0.1 mg
EUR 269

Anti-Hu CD3 zeta (pY111) Alexa Fluor® 647

A6-737-C100 0.1 mg
EUR 269

Anti-LAMP3 (human) Monoclonal Antibody (104G4) (Alexa Fluor® 488)

M09406 100ug
EUR 565
Description: Mouse Monoclonal LAMP3 (human) Antibody (104G4) (Alexa Fluor® 488). Validated in IHC and tested in Human.

Anti-Langerin (human) Monoclonal Antibody (DCGM4/122D5) (Alexa Fluor® 488)

M02316 100ug
EUR 580
Description: Mouse Monoclonal Langerin (human) Antibody (DCGM4/122D5) (Alexa Fluor® 488). Validated in IHC and tested in Human.

Rabbit Anti-Rat IgG (H+L)-Alexa 488 Fluor conjugate (adsorbed with human IgG)

50336 0.5 ml
EUR 225

Rabbit Anti-Rat IgG (H+L)-Alexa 594 Fluor conjugate (adsorbed with human IgG)

50337 0.5 ml
EUR 225

AG 555

B6377-10 10 mg
EUR 144
Description: AG 555 is a potent and selective inhibitor of EGFR with IC50 value of 0.7 ?M. The epidermal growth factor receptor (EGFR) is the cell-surface receptor for epidermal growth factor and plays an important role in tumor invasion and cancer cell proliferation.

AG 555

B6377-25 25 mg
EUR 276
Description: AG 555 is a potent and selective inhibitor of EGFR with IC50 value of 0.7 ?M. The epidermal growth factor receptor (EGFR) is the cell-surface receptor for epidermal growth factor and plays an important role in tumor invasion and cancer cell proliferation.

AG 555

B6377-50 50 mg
EUR 447
Description: AG 555 is a potent and selective inhibitor of EGFR with IC50 value of 0.7 ?M. The epidermal growth factor receptor (EGFR) is the cell-surface receptor for epidermal growth factor and plays an important role in tumor invasion and cancer cell proliferation.

MCC-555

C4892-1 1 mg
EUR 158
Description: MCC-555, also known as RWJ-241947, is a novel peroxisome proliferator?activated receptor ? ligand [1]. The PPAR? receptors mainly express in adipose tissue, colon and macrophages involved in regulating fatty acid storage and glucose metabolism.

MCC-555

C4892-10 10 mg
EUR 918
Description: MCC-555, also known as RWJ-241947, is a novel peroxisome proliferator?activated receptor ? ligand [1]. The PPAR? receptors mainly express in adipose tissue, colon and macrophages involved in regulating fatty acid storage and glucose metabolism.

MCC-555

C4892-5 5 mg
EUR 538
Description: MCC-555, also known as RWJ-241947, is a novel peroxisome proliferator?activated receptor ? ligand [1]. The PPAR? receptors mainly express in adipose tissue, colon and macrophages involved in regulating fatty acid storage and glucose metabolism.

AG 555

HY-15336 10mM/1mL
EUR 126

Recombinant (E.Coli, His-tag) HIV-1 pol Integrase

RP-555 10 ug
EUR 164

Alpha Fluor™ 488 amine

1705 1 mg
EUR 306
  • R-phrase: R20, R21, R22
  • H-Phrase: H303, H313, H333
  • Symbol for dangerous compounds: Xn
  • UNSPEC Code: 12171501

Alpha Fluor™ 488 Hydroxylamine

1900 1 mg
EUR 306
  • R-phrase: R20, R21, R22
  • H-Phrase: H303, H313, H333
  • Symbol for dangerous compounds: Xn
  • UNSPEC Code: 12171501

Tide Fluor 2-LL-37

H-8286.0100 0.1mg
EUR 312
Description: Sum Formula: C205H340N60O53+dye

Tide Fluor 2-LL-37

H-8286.0500 0.5mg
EUR 1017
Description: Sum Formula: C205H340N60O53+dye

Anti-Cytokeratins Alexa Fluor488

A4-108-C025 0.025 mg
EUR 175

Anti-Cytokeratins Alexa Fluor488

A4-108-C100 0.1 mg
EUR 310

Anti-PSMA Alexa Fluor488

A4-539-C025 0.025 mg
EUR 227

Anti-PSMA Alexa Fluor488

A4-539-C100 0.1 mg
EUR 414

Anti-FoxP3 Alexa Fluor488

A4-601-C025 0.025 mg
EUR 201

Anti-FoxP3 Alexa Fluor488

A4-601-C100 0.1 mg
EUR 362

Anti-Phosphotyrosine Alexa Fluor647

A6-263-C025 0.025 mg
EUR 154

Anti-Phosphotyrosine Alexa Fluor647

A6-263-C100 0.1 mg
EUR 269

Anti-LCK Alexa Fluor647

A6-269-C025 0.025 mg
EUR 206

Anti-LCK Alexa Fluor647

A6-269-C100 0.1 mg
EUR 373

Anti-FoxP3 Alexa Fluor647

A6-601-C025 0.025 mg
EUR 201

Anti-FoxP3 Alexa Fluor647

A6-601-C100 0.1 mg
EUR 362

CellBrite Fix 555

30088 1KIT
EUR 563
Description: Minimum order quantity: 1 unit of 1KIT

Cyanine 555 aminooxy

96009 1MG
EUR 342
Description: Minimum order quantity: 1 unit of 1MG

Cyanine 555 tyramide

96020 0.5mg
EUR 353
Description: Minimum order quantity: 1 unit of 0.5mg

Cyanine 555 alkyne

92100 1MG
EUR 226
Description: Minimum order quantity: 1 unit of 1MG

Monoclonal Anti-Monkey IgG-Alexa 555 Conj. (specific for monkey; no reactivity with human or animals IgG)

70030-AF555 50 tests
EUR 347

Metal Fluor™ Zn-520, AM

21263 1 mg
EUR 219
  • R-phrase: R20, R21, R22
  • H-Phrase: H303, H313, H333
  • Symbol for dangerous compounds: Xn
  • UNSPEC Code: 12352200

Alpha Fluor™ 488 NHS Ester

1812 1 mg
EUR 219
  • R-phrase: R20, R21, R22
  • H-Phrase: H303, H313, H333
  • Symbol for dangerous compounds: Xn
  • UNSPEC Code: 12171501

Alpha Fluor™ 532 NHS Ester

1819 1 mg
EUR 219
  • R-phrase: R20, R21, R22
  • H-Phrase: H303, H313, H333
  • Symbol for dangerous compounds: Xn
  • UNSPEC Code: 12171501

Alpha Fluor™ 594 C5 Maleimide

1891 1 mg
EUR 219
  • R-phrase: R20, R21, R22
  • H-Phrase: H303, H313, H333
  • Symbol for dangerous compounds: Xn
  • UNSPEC Code: 12171501

Helix Fluor™ 6-JOE Phosphoramidite

6046 100 umoles
EUR 50
  • R-phrase: R20, R21, R22
  • H-Phrase: H303, H313, H333
  • Symbol for dangerous compounds: Xn
  • UNSPEC Code: 12171501

Tide Fluor 2-LL-37 (scrambled)

H-8288.0100 0.1mg
EUR 312
Description: Sum Formula: C205H340N60O53+dye

Tide Fluor 2-LL-37 (scrambled)

H-8288.0500 0.5mg
EUR 1017
Description: Sum Formula: C205H340N60O53+dye

Tide Fluor 5WS-o-Conotoxin GVIA

H-8356.0100 0.1mg
EUR 1146
Description: Sum Formula: C120H182N38O43S6+dye

Streptavidin-Alexa488 (Alexas fluor 488) conjugate

SV-A488-100 100 tests
EUR 225

Streptavidin-Alexa594 (Alexas fluor 594) conjugate

SV-A594-100 100 tests
EUR 225

Anti-Cytokeratin 18 Alexa Fluor488

A4-106-C025 0.025 mg
EUR 186

Anti-Cytokeratin 18 Alexa Fluor488

A4-106-C100 0.1 mg
EUR 331

Anti-Cytokeratin 19 Alexa Fluor488

A4-120-C025 0.025 mg
EUR 186

Anti-Cytokeratin 19 Alexa Fluor488

A4-120-C100 0.1 mg
EUR 331

Anti-Ki-67 Alexa Fluor488

A4-155-T025 25 tests
EUR 154

Anti-Ki-67 Alexa Fluor488

A4-155-T100 100 tests
EUR 269

Anti-Hu CD45 Alexa Fluor488

A4-160-T100 100 tests
EUR 269

Anti-Hu CD193 Alexa Fluor488

A4-161-T100 100 tests
EUR 269

Anti-Hu CD279 Alexa Fluor488

A4-176-T100 100 tests
EUR 269

Anti-Hu CD43 Alexa Fluor488

A4-220-T025 25 tests
EUR 154

Anti-Hu CD43 Alexa Fluor488

A4-220-T100 100 tests
EUR 269

Anti-Hu CD44 Alexa Fluor488

A4-221-T025 25 tests
EUR 154

Anti-Hu CD44 Alexa Fluor488

A4-221-T100 100 tests
EUR 269

Anti-Hu CD45 Alexa Fluor488

A4-222-T025 25 tests
EUR 154

Anti-Hu CD45 Alexa Fluor488

A4-222-T100 100 tests
EUR 269

Anti-Hu CD55 Alexa Fluor488

A4-230-T025 25 tests
EUR 154

Anti-Hu CD55 Alexa Fluor488

A4-230-T100 100 tests
EUR 269

Anti-Hu CD50 Alexa Fluor488

A4-266-T025 25 tests
EUR 154

Anti-Hu CD50 Alexa Fluor488

A4-266-T100 100 tests
EUR 269

Anti-Hu CD31 Alexa Fluor488

A4-273-T025 25 tests
EUR 154

Anti-Hu CD31 Alexa Fluor488

A4-273-T100 100 tests
EUR 269

Anti-Hu CD147 Alexa Fluor488

A4-274-T025 25 tests
EUR 154

Anti-Hu CD147 Alexa Fluor488

A4-274-T100 100 tests
EUR 269

Anti-Hu CD34 Alexa Fluor488

A4-297-T025 25 tests
EUR 154

Anti-Hu CD34 Alexa Fluor488

A4-297-T100 100 tests
EUR 269

Anti-Hu CD105 Alexa Fluor488

A4-298-T025 25 tests
EUR 154

Anti-Hu CD105 Alexa Fluor488

A4-298-T100 100 tests
EUR 269

Anti-Hu CD41 Alexa Fluor488

A4-309-T025 25 tests
EUR 154

Anti-Hu CD41 Alexa Fluor488

A4-309-T100 100 tests
EUR 269

Anti-Hu CD72 Alexa Fluor488

A4-310-T025 25 tests
EUR 154

Anti-Hu CD63 Alexa Fluor488

A4-343-T025 25 tests
EUR 154

Anti-Hu CD63 Alexa Fluor488

A4-343-T100 100 tests
EUR 269

Anti-Hu CD13 Alexa Fluor488

A4-396-T025 25 tests
EUR 154

Anti-Hu CD13 Alexa Fluor488

A4-396-T100 100 tests
EUR 269

Anti-HLA-G Alexa Fluor488

A4-431-C025 0.025 mg
EUR 217

Anti-HLA-G Alexa Fluor488

A4-431-C100 0.1 mg
EUR 394

Anti-HLA-G Alexa Fluor488

A4-437-C025 0.025 mg
EUR 217

Anti-HLA-G Alexa Fluor488

A4-437-C100 0.1 mg
EUR 394

Anti-Hu CD300a Alexa Fluor488

A4-501-T100 100 tests
EUR 269

Anti-HLA-A2 Alexa Fluor488

A4-556-T025 25 tests
EUR 154

Anti-HLA-A2 Alexa Fluor488

A4-556-T100 100 tests
EUR 269

Anti-CD3 zeta Alexa Fluor488

A4-568-C100 0.1 mg
EUR 269

Anti-Ms CD8a Alexa Fluor488

A4-579-C025 0.025 mg
EUR 139

Anti-Ms CD8a Alexa Fluor488

A4-579-C100 0.1 mg
EUR 238

Anti-Hu CD326 Alexa Fluor488

A4-582-T100 100 tests
EUR 269

Anti-Hu CD3 Alexa Fluor488

A4-631-T100 100 tests
EUR 269

Anti-Hu CD16 Alexa Fluor488

A4-646-T025 25 tests
EUR 154

Anti-Hu CD150 Alexa Fluor488

A4-660-T100 100 tests
EUR 269
Pattern variability is assessed by learning tissue phantoms much like these used within the experimental verification of the approach and which can be consultant of (irregular) dental tissues. For tissue characterization, good restoration of the built-in attenuation ensues by using spatially compact radiation sources. For tissue imaging, spatially prolonged sources with broad bandwidth are superior because of the implicit longitudinal coherence filter. For each functions, pattern variability points could also be neutralized by allowing spatial divergence of scattered photons.

Leave a Reply

Your email address will not be published. Required fields are marked *